| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000001560 |
| Receipt No. | R000001885 |
| Official scientific title of the study | A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancer |
| Date of disclosure of the study information | 2008/12/10 |
| Last modified on | 2019/01/28 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancer | |
| Title of the study (Brief title) | A randomized phase II trial of UFT/LV versus S-1 adjuvant therapy in patients with stage III colorectal cancer | |
| Region |
|
|
| Condition | ||
| Condition | stage III colorectal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of adjuvant chemotherapy with S-1 for curative resection for stage III colorectal cancer |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | 3-year disease free survival rate |
| Key secondary outcomes | overall survival |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | UFT 300mg per m2 per day and LV 75mg per day for 28 days every 5-weeks for 6 months | |
| Interventions/Control_2 | TS-1 80mg per m2 per day for 28 days every 6-weeks for 12 months | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Histological Stage III colorectal adenocarcinoma
2. Resection of histological curability A was performed 3. 20-80 years old 4. No prior chemotherapy and radiotherapy 5. Performance status(ECOG):0 or 1 6. Sufficient organ functions 7. Written informed consent |
|||
| Key exclusion criteria | 1. Severe postoperative complication
2. Serious coexisting illness 1)uncontrolled diabetes mellitus and hypertension 2)history of myocardial infarction, unstable angina within 6 months prior to the registrationsevere 3)pulmonary dysfunction 3. Active diarrhea 4. Multiple cancer 5. Pregnant 6. Disqualified by attending doctor |
|||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Keiji Koda |
| Organization | Teikyo University Chiba Medical Center |
| Division name | Department of surgery |
| Address | 3426-3 Anegasaki, Ichihara, Japan |
| TEL | 0436-62-1211 |
| k-koda@med.teikyo-u.ac.jp | |
| Public contact | |
| Name of contact person | Hideaki Miyauchi |
| Organization | Graduate school of medicine |
| Division name | Department of frontier surgery |
| Address | 1-8-1 Inohana, Chu0-ku, Chiba, Japan |
| TEL | 043-226-2109 |
| Homepage URL | |
| miyahide@faculty.chiba-u.jp | |
| Sponsor | |
| Institute | Boso Clinical Oncology Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001885 |